Status not kept up to date
Multimodal Instrumented Assessment of Post-stroke Elbow
NCT04484571 · Azienda USL Toscana Nord Ovest · Updated 25 July 2023
- What is being tested
- Neuroexsos elbow module
- For
- Spasticity, Muscle; Stroke; Upper Limb
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 60 people. The full rules are on the registry page.
- Where
- Italy
- When
- Starts or started 6 July 2020, ends 30 July 2024. Registered 23 July 2020.
- Results
- None posted yet.
In the researchers' words
The proposed clinical trial will employ the NEUROExos Elbow Module (NEEM), an active robotic exoskeleton, for the passive mobilization and active training of elbow flexion and extension in 60 sub-acute and chronic stroke patients with motor impairments (hemiparesis and/or spasticity) of the right arm. The study protocol is a randomized controlled trial consisting of a 4-week functional rehabilitation program, with both clinical and robotically instrumented assessments to be conducted at baseline and post-treatment.
Sites
- Ospedale VersiliaCamaiore, Lucca, Italy